Chimerix(us:CMRX)
8.50
-0.12%
Updated on 2025-04-02
Open:8.50
Close:8.50
High:8.51
Low:8.50
Prev Close:8.51
Volume:1.75M
Turnover:14.86M
Turnover Ratio:1.86%
Shares:93.80M
MarketCap:797.33M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 1 | 310 | 0.00% | 0 | 1 | 0 |
| 2024-03-31 | 91 | 38761787 | 43.25% | 16 | 14 | 38 |
| 2023-12-31 | 91 | 40518831 | 45.56% | 11 | 18 | 42 |
| 2023-09-30 | 102 | 40221528 | 45.25% | 8 | 19 | 53 |
| 2023-06-30 | 121 | 39094518 | 44.13% | 26 | 26 | 58 |
| 2023-03-31 | 113 | 52305492 | 59.05% | 11 | 30 | 49 |
| 2022-12-31 | 131 | 52206875 | 59.29% | 16 | 42 | 58 |
| 2022-09-30 | 137 | 50191679 | 57.01% | 22 | 40 | 54 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Ra Capital Management, L.P. | 8800000 | 9.82% | 0 | |
| 2024-03-31 | Monaco Asset Management Sam | 4377674 | 4.88% | 0 | |
| 2024-03-31 | Vanguard Group Inc | 4345579 | 4.85% | 0 | |
| 2024-03-31 | Armistice Capital, Llc | 2264000 | 2.53% | -334000 | -12.86% |
| 2024-03-31 | Acadian Asset Management Llc | 2174813 | 2.43% | 291981 | 15.51% |
| 2024-03-31 | Citadel Advisors Llc | 1895187 | 2.11% | -167363 | -8.11% |
| 2024-03-31 | Renaissance Technologies Llc | 1853815 | 2.07% | 291806 | 18.68% |
| 2024-03-31 | Vestal Point Capital, Lp | 1400000 | 1.56% | 0 | |
| 2024-03-31 | Goldman Sachs Group Inc | 1159481 | 1.29% | -20052 | -1.70% |
| 2024-03-31 | Millennium Management Llc | 1090935 | 1.22% | 3332 | 0.31% |
About
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.
Address:2505 Meridian Parkway,Suite 100
Website:http://www.chimerix.com
Market Movers